文献速递腹部CT

胰腺弥漫性受累并非总是自身免疫性胰腺炎

Diffuse Involvement of Pancreas is not Always Autoimmune Pancreatitis.
PubMed 文献 · Acad Radiol · 2022-03-09

单中心研究分析245例胰腺弥漫性受累患者的增强CT,恶性病变占45.3%,良性均为自身免疫性胰腺炎,最常见恶性为胰腺导管腺癌;残余正常胰腺实质、不均匀性、短轴3.15 cm及LARDP 0.75为恶性独立预测因子,联合敏感度94.2%、特异度90.8%。

要点

  • 胰腺弥漫性受累者中恶性病变占45.3%,良性均为自身免疫性胰腺炎,不可仅凭弥漫受累诊断自身免疫性胰腺炎。
  • 残余正常胰腺实质、不均匀性、短轴≥3.15 cm、LARDP≤0.75为恶性独立预测因子。
  • 上述预测因子联合诊断恶性敏感度94.2%、特异度90.8%。

核心结论

  • 胰腺弥漫性受累少见且非自身免疫性胰腺炎的特异性征象,与多种恶性病变相关,动态增强CT有助于鉴别恶性病变。

关键影像表现/征象

  • 评估胰腺动脉期、门脉期及延迟期的病灶-主动脉强化比值(LAR)及传统CT表现。
  • 残余正常胰腺实质、不均匀性、短轴及LARDP为恶性独立预测因子。

诊断标准与关键数值

  • 恶性病变占胰腺弥漫性增大的45.3%(111/245),良性病变均为自身免疫性胰腺炎,占54.7%(134例)。
  • 最常见恶性病变为胰腺导管腺癌(88例,35.9%),其他包括胰腺神经内分泌肿瘤(11例,4.5%)、淋巴瘤(4例,1.6%)、转移瘤(4例,1.6%)、实性假乳头状肿瘤(3例,1.2%)及腺泡细胞癌(1例,0.4%)。
  • 短轴截断值3.15 cm、LARDP截断值0.75为恶性独立预测因子。
  • 上述预测因子联合诊断恶性敏感度94.2%、特异度90.8%。

临床应用与阅片要点

  • 阅片遇胰腺弥漫性受累时,需结合残余正常胰腺实质、不均匀性、短轴≥3.15 cm及LARDP≤0.75等征象鉴别恶性病变与自身免疫性胰腺炎。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To determine the prevalence of diffuse involvement of pancreas and to identify the findings of malignancies using enhancement computed tomography (CT).

MATERIALS AND METHODS: A total of 1,0249 patients performed enhancement CT in our hospital over 62 months were investigated and the final study cohort includes 245 patients (170 males, 75 females; mean age, 56.94 ± 12.17 years). The reference standard is the final clinical/pathological diagnosis. The lesion-to-aorta enhancement ratio (LAR) on the pancreatic arterial phase, portal phase and delayed phase (DP) and the traditional CT findings were evaluated. Intergroup comparisons between malignancies and non-malignancies lesions were performed. Univariate and multivariate analyses were conducted to identify findings predicting malignancies.

RESULTS: The prevalence of malignancy was 45.3% (111/245) of diffuse enlargement of pancreas. All benign lesions were autoimmune pancreatitis 54.7% (n = 134). The most common malignant lesion was pancreatic ductal adenocarcinoma (n = 88, 35.9%). Other rare lesions with malignant potential included pancreatic neuroendocrine tumor (n = 11, 4.5%), lymphoma (n = 4, 1.6%), metastasis (n = 4, 1.6%), solid pseudopapillary neoplasm (n = 3, 1.2%) and acinar cell carcinoma (n = 1, 0.4%). Residual normal pancreas parenchyma, heterogeneity, short axis (cut-off value, 3.15 cm) and LARDP (cut-off value, 0.75) were independent predictors of malignancies. When the above predictors were combined, a sensitivity of 94.2%, a specificity of 90.8% were attained.

CONCLUSION: Diffuse involvement of the pancreas is rare and is not a specific sign of autoimmune pancreatitis, and it is associated with a wide spectrum of malignant conditions. Dynamic enhancement CT is helpful to identifying malignancies.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. He, Wang, Xu, et al. Diffuse Involvement of Pancreas is not Always Autoimmune Pancreatitis. Acad Radiol. 2022. PMID: 35279380. doi:10.1016/j.acra.2022.01.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。